These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37852787)

  • 1. What Are the Risks of Guillain-Barré Syndrome After SARS-CoV-2 Infection and COVID-19 Vaccination?
    Bourdette D; Silbermann E
    Neurology; 2023 Nov; 101(20):875-876. PubMed ID: 37852787
    [No Abstract]   [Full Text] [Related]  

  • 2. Guillain-Barré Syndrome Associated with COVID-19 Vaccination.
    Finsterer J; Scorza FA; Scorza CA
    Emerg Infect Dis; 2022 May; 28(5):1079-1080. PubMed ID: 35447058
    [No Abstract]   [Full Text] [Related]  

  • 3. Guillain-Barre syndrome related to SARS-CoV-2 vaccinations.
    Finsterer J; Scorza CA; Scorza FA
    Clinics (Sao Paulo); 2022; 77():100113. PubMed ID: 36137343
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.
    Li X; Raventós B; Roel E; Pistillo A; Martinez-Hernandez E; Delmestri A; Reyes C; Strauss V; Prieto-Alhambra D; Burn E; Duarte-Salles T
    BMJ; 2022 Mar; 376():e068373. PubMed ID: 35296468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barré Syndrome Following the BNT162b2 mRNA COVID-19 Vaccine.
    Algahtani HA; Shirah BH; Albeladi YK; Albeladi RK
    Acta Neurol Taiwan; 2023 Jun; 32(2)():82-85. PubMed ID: 37198513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Guillain-Barré Syndrome and COVID-19 Infection and Vaccination: A Population-Based Nested Case-Control Study.
    Bishara H; Arbel A; Barnett-Griness O; Bloch S; Cohen S; Najjar-Debbiny R; Gronich N; Auriel E; Saliba W
    Neurology; 2023 Nov; 101(20):e2035-e2042. PubMed ID: 37852786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report.
    Masuccio FG; Comi C; Solaro C
    Acta Neurol Belg; 2022 Oct; 122(5):1369-1371. PubMed ID: 34767184
    [No Abstract]   [Full Text] [Related]  

  • 8. Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?
    Introna A; Caputo F; Santoro C; Guerra T; Ucci M; Mezzapesa DM; Trojano M
    Clin Neurol Neurosurg; 2021 Sep; 208():106887. PubMed ID: 34418708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 vaccination triggered Guillain-Barre syndrome.
    Scorza FA; Finsterer J
    Clin Neurol Neurosurg; 2022 Feb; 213():107106. PubMed ID: 34974378
    [No Abstract]   [Full Text] [Related]  

  • 10. Comment on "SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fiber neuropathy by J. Finsterer.
    Galassi G
    J Neuroimmunol; 2022 Aug; 369():577901. PubMed ID: 35667183
    [No Abstract]   [Full Text] [Related]  

  • 11. SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy.
    Baars AE; Kuitwaard K; de Koning LC; Luijten LWG; Kok WM; Eftimov F; Wieske L; Goedee HS; van der Pol WL; Blomkwist-Markens PH; Horemans AMC; Jacobs BC; van Doorn PA
    Neurology; 2023 Jan; 100(2):e182-e191. PubMed ID: 36127144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain-Barre syndrome should be monitored upon mass vaccination against SARS-CoV-2.
    Leung C
    Hum Vaccin Immunother; 2021 Sep; 17(9):2957-2958. PubMed ID: 34032555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world data on the incidence and risk of Guillain-Barré syndrome following SARS-CoV-2 vaccination: a prospective surveillance study.
    Ha J; Park S; Kang H; Kyung T; Kim N; Kim DK; Kim H; Bae K; Song MC; Lee KJ; Lee E; Hwang BS; Youn J; Seok JM; Park K
    Sci Rep; 2023 Mar; 13(1):3773. PubMed ID: 36882454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guillain-Barre syndrome and thrombocytopenia after SARS-CoV-2 vaccination with Moderna. A case report].
    Lázaro C; Llauradó A; Sánchez-Tejerina D; Cabirta A; Carpio C; Sotoca J; Salvadó M; Raguer N; Restrepo J; Juntas R
    Rev Neurol; 2022 Oct; 75(8):247-250. PubMed ID: 36218255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter to the Editor: Pre-Existing Neuropathy Favours SARS-CoV-2 Vaccination Associated Guillain-Barre Syndrome.
    Finsterer J
    J Korean Med Sci; 2022 Jul; 37(26):e217. PubMed ID: 35790211
    [No Abstract]   [Full Text] [Related]  

  • 16. Reader Response: SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy.
    Harth CE
    Neurology; 2023 Jul; 101(1):50-51. PubMed ID: 37400257
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of COVID-19 vaccine type on Guillain-Barré syndrome: Two cases and a literature review.
    Lee HY; Lien WC
    Hum Vaccin Immunother; 2023 Dec; 19(1):2171231. PubMed ID: 36919452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Author Response: SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy.
    Baars AE; Van Doorn PA; Jacobs BC; Kuitwaard K
    Neurology; 2023 Jul; 101(1):51. PubMed ID: 37400258
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.
    Shoraka S; Ferreira MLB; Mohebbi SR; Ghaemi A
    Front Immunol; 2021; 12():674922. PubMed ID: 34040615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case Report of Guillain-Barré Syndrome In Association with SARS-CoV-2 Vaccination in Malaysia.
    Sii HL; Ng SH; Wong VF; Law WC
    Acta Neurol Taiwan; 2023 Dec; 32(4)():207-211. PubMed ID: 37723913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.